Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor

2021
journal article
article
16
dc.affiliationWydział Lekarski : Klinika Hematologiipl
dc.cm.date2022-04-08T06:19:19Z
dc.cm.id105798pl
dc.cm.idOmegaUJCM7a2a5fdfbcd5426bb566f019bcc84208pl
dc.contributor.authorStaber, Philipp Bernhardpl
dc.contributor.authorJurczak, Wojciech - 129923 pl
dc.contributor.authorGreil, Richardpl
dc.contributor.authorVucinic, Vladanpl
dc.contributor.authorMiddeke, Jan Moritzpl
dc.contributor.authorMontillo, Marcopl
dc.contributor.authorMunir, Talhapl
dc.contributor.authorNeumeister, Peterpl
dc.contributor.authorSchetelig, Johannespl
dc.contributor.authorStilgenbauer, Stephanpl
dc.contributor.authorStriebel, Frankpl
dc.contributor.authorDirnberger-Hertweck, Marenpl
dc.contributor.authorWeirather, Johannespl
dc.contributor.authorBrugger, Wolframpl
dc.contributor.authorKelemen, Peterpl
dc.contributor.authorWendtner, Clemens-Martinpl
dc.contributor.authorWoyach, Jennifer Annpl
dc.date.accession2022-02-01pl
dc.date.accessioned2022-04-08T06:19:19Z
dc.date.available2022-04-08T06:19:19Z
dc.date.issued2021pl
dc.description.number14pl
dc.description.physical3440-3451pl
dc.description.volume62pl
dc.identifier.doi10.1080/10428194.2021.1964020pl
dc.identifier.eissn1029-2403pl
dc.identifier.issn1042-8194pl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/290233
dc.languageengpl
dc.language.containerengpl
dc.rightsDodaję tylko opis bibliograficzny*
dc.rights.licenceBez licencji otwartego dostępu
dc.rights.uri*
dc.source.integratorfalse
dc.subtypeArticlepl
dc.titleTafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitorpl
dc.title.journalLeukemia and Lymphomapl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.affiliationpl
Wydział Lekarski : Klinika Hematologii
dc.cm.date
2022-04-08T06:19:19Z
dc.cm.idpl
105798
dc.cm.idOmegapl
UJCM7a2a5fdfbcd5426bb566f019bcc84208
dc.contributor.authorpl
Staber, Philipp Bernhard
dc.contributor.authorpl
Jurczak, Wojciech - 129923
dc.contributor.authorpl
Greil, Richard
dc.contributor.authorpl
Vucinic, Vladan
dc.contributor.authorpl
Middeke, Jan Moritz
dc.contributor.authorpl
Montillo, Marco
dc.contributor.authorpl
Munir, Talha
dc.contributor.authorpl
Neumeister, Peter
dc.contributor.authorpl
Schetelig, Johannes
dc.contributor.authorpl
Stilgenbauer, Stephan
dc.contributor.authorpl
Striebel, Frank
dc.contributor.authorpl
Dirnberger-Hertweck, Maren
dc.contributor.authorpl
Weirather, Johannes
dc.contributor.authorpl
Brugger, Wolfram
dc.contributor.authorpl
Kelemen, Peter
dc.contributor.authorpl
Wendtner, Clemens-Martin
dc.contributor.authorpl
Woyach, Jennifer Ann
dc.date.accessionpl
2022-02-01
dc.date.accessioned
2022-04-08T06:19:19Z
dc.date.available
2022-04-08T06:19:19Z
dc.date.issuedpl
2021
dc.description.numberpl
14
dc.description.physicalpl
3440-3451
dc.description.volumepl
62
dc.identifier.doipl
10.1080/10428194.2021.1964020
dc.identifier.eissnpl
1029-2403
dc.identifier.issnpl
1042-8194
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/290233
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Dodaję tylko opis bibliograficzny
dc.rights.licence
Bez licencji otwartego dostępu
dc.rights.uri*
dc.source.integrator
false
dc.subtypepl
Article
dc.titlepl
Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor
dc.title.journalpl
Leukemia and Lymphoma
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
15
Views per month
Views per city
Ashburn
2
Krakow
2
Tokyo
2
Wroclaw
2
Beijing
1
Calgary
1
Dublin
1
Lappeenranta
1
Royal Leamington Spa
1

No access

No Thumbnail Available